Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine-Reference-Cited by-同舟云学术

Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine

Published:2016-01-29 Issue:7 Volume:7 Page:8360-8372
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wang Cheng¹,Liu Biao²,Xu Xuelian¹,Zhuang Bo¹,Li Hongxia¹,Yin Jiaqi¹,Cong Mengyi¹,Xu Wei³⁴,Lu Aiping²

Affiliation:

1. Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China

2. Institute for Advancing Translational Medicine in Bone and Joint Diseases, Jockey Club School of Chinese Medicine Building, Hong Kong Baptist University, Kowloon Tong, Kowloon, Hong Kong

3. Department of Pharmacy, Shandong Provincial Qian Foshan Hospital, Jinan, China

4. Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on phytochemicals in the treatment and prevention of pancreatic cancer: Focusing on their mechanism of action;Health Science Reports;2024-04-29

2. Drug repurposing for cancer therapy;Signal Transduction and Targeted Therapy;2024-04-19

3. Aptamers for the Delivery of Plant-Based Compounds: A Review;Pharmaceutics;2024-04-14

4. Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia;Cancer Letters;2024-04

5. Mechanisms of cancer cell death induction by triptolide: A comprehensive overview;Heliyon;2024-01